SuperworthVir Biotechnology shares outstanding VIR
Diluted shares outstanding, averaged over each quarter, from 2018.
- Latest quarter, to Jun 30, 2026
- 168.9M
- On a year earlier
- +22.0%
- more shares
Vir Biotechnology had 168.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 22.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 139.2M | +2% |
| FY2024 | 136.8M | +2% |
| FY2023 | 134.6M | +1% |
| FY2022 | 133.2M | −0% |
| FY2021 | 133.8M | +5% |
| FY2020 | 127.3M | +1371% |
| FY2018 | 8.7M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 168.9M | +22% | |
| Q1 FY26 | 147.4M | +7% | |
| Q4 FY25 | 139.2M | +2% | |
| Q3 FY25 | 138.9M | +2% | |
| Q2 FY25 | 138.4M | +2% | |
| Q1 FY25 | 137.5M | +2% | |
| Q4 FY24 | 136.8M | +2% | |
| Q3 FY24 | 136.7M | +2% | |
| Q2 FY24 | 136.2M | +2% | |
| Q1 FY24 | 135.3M | +1% | |
| Q4 FY23 | 134.6M | +1% | |
| Q3 FY23 | 134.3M | −0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Vir Biotechnology
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.